PAREXEL Intl Corp. (PRXL)
NASDAQ: PRXL
· Real-Time Price · USD
88.08
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
PAREXEL Intl Revenue Breakdown
| Period Ending | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Mar 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Research Services Revenue | 409.1M | 408.9M | 376.3M | 402.8M | 407.1M | 410.2M | 384.78M | 377.4M | 369.81M | 373.22M | 363.87M | 332.59M | 342.39M | 320.58M | 297.17M | 263.37M |
| Clinical Research Services Revenue Growth | +0.05% | +8.66% | -6.58% | -1.06% | -0.76% | +6.61% | +1.95% | +2.05% | -0.91% | +2.57% | +9.40% | -2.86% | +6.80% | +7.88% | +12.83% | n/a |
| Parexel Consulting And Medcom Services Revenue | 50.7M | 54.6M | 55M | 49.9M | 41.4M | 39.3M | 50.07M | 56.03M | 56.4M | 51.88M | 55.53M | 53.54M | 50.61M | 49.27M | 48.35M | 43.3M |
| Parexel Consulting And Medcom Services Revenue Growth | -7.14% | -0.73% | +10.22% | +20.53% | +5.34% | -21.51% | -10.64% | -0.65% | +8.70% | -6.58% | +3.73% | +5.78% | +2.71% | +1.91% | +11.66% | n/a |
| Perceptive Informatics Inc Revenue | 69.5M | 70.9M | 65.4M | 74.4M | 70M | 62.6M | 67.18M | 65.83M | 65.49M | 67.28M | 67.75M | 63.12M | 61.49M | 52.21M | 49.23M | 49.32M |
| Perceptive Informatics Inc Revenue Growth | -1.97% | +8.41% | -12.10% | +6.29% | +11.82% | -6.82% | +2.05% | +0.53% | -2.66% | -0.69% | +7.34% | +2.64% | +17.77% | +6.05% | -0.17% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 95.2M | 173.6M | 170.6M | 169.4M | 76.8M | 179.1M | 181M | 166.4M | 57.06M | 160.99M |
| Selling, General, and Administrative Revenue Growth | -45.16% | +1.76% | +0.71% | +120.57% | -57.12% | -1.05% | +8.77% | +191.64% | -64.56% | n/a |
| Research and Development Revenue | 17.8M | n/a | n/a | n/a | 19.2M | n/a | n/a | n/a | 24M | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a |